BIOMAT Database Logo BIOMAT Database Logo

Hemodynamic effects of calcium antagonists. Review. 1983

H U Lehmann, and H Hochrein, and E Witt, and H W Mies

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D009543 Nifedipine A potent vasodilator agent with calcium antagonistic action. It is a useful anti-anginal agent that also lowers blood pressure. Adalat,BAY-a-1040,Bay-1040,Cordipin,Cordipine,Corinfar,Fenigidin,Korinfar,Nifangin,Nifedipine Monohydrochloride,Nifedipine-GTIS,Procardia,Procardia XL,Vascard,BAY a 1040,BAYa1040,Bay 1040,Bay1040,Monohydrochloride, Nifedipine,Nifedipine GTIS
D009568 Nitrendipine A calcium channel blocker with marked vasodilator action. It is an effective antihypertensive agent and differs from other calcium channel blockers in that it does not reduce glomerular filtration rate and is mildly natriuretic, rather than sodium retentive. Balminil,Bay e 5009,Bayotensin,Baypresol,Baypress,Gericin,Jutapress,Nidrel,Niprina,Nitre AbZ,Nitre-Puren,Nitregamma,Nitren 1A Pharma,Nitren Lich,Nitren acis,Nitrend KSK,Nitrendepat,Nitrendi Biochemie,Nitrendidoc,Nitrendimerck,Nitrendipin AL,Nitrendipin Apogepha,Nitrendipin Atid,Nitrendipin Basics,Nitrendipin Heumann,Nitrendipin Jenapharm,Nitrendipin Lindo,Nitrendipin Stada,Nitrendipin beta,Nitrendipin-ratiopharm,Nitrendipino Bayvit,Nitrendipino Ratiopharm,Nitrensal,Nitrepress,Tensogradal,Trendinol,Vastensium,nitrendipin von ct,nitrendipin-corax,Nitre Puren,NitrePuren,Nitrendipin ratiopharm,Nitrendipinratiopharm,nitrendipin corax,nitrendipincorax
D002121 Calcium Channel Blockers A class of drugs that act by selective inhibition of calcium influx through cellular membranes. Calcium Antagonists, Exogenous,Calcium Blockaders, Exogenous,Calcium Channel Antagonist,Calcium Channel Blocker,Calcium Channel Blocking Drug,Calcium Inhibitors, Exogenous,Channel Blockers, Calcium,Exogenous Calcium Blockader,Exogenous Calcium Inhibitor,Calcium Channel Antagonists,Calcium Channel Blocking Drugs,Exogenous Calcium Antagonists,Exogenous Calcium Blockaders,Exogenous Calcium Inhibitors,Antagonist, Calcium Channel,Antagonists, Calcium Channel,Antagonists, Exogenous Calcium,Blockader, Exogenous Calcium,Blocker, Calcium Channel,Blockers, Calcium Channel,Calcium Blockader, Exogenous,Calcium Inhibitor, Exogenous,Channel Antagonist, Calcium,Channel Blocker, Calcium,Inhibitor, Exogenous Calcium
D003327 Coronary Disease An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels. Coronary Heart Disease,Coronary Diseases,Coronary Heart Diseases,Disease, Coronary,Disease, Coronary Heart,Diseases, Coronary,Diseases, Coronary Heart,Heart Disease, Coronary,Heart Diseases, Coronary
D003402 Creatine Kinase A transferase that catalyzes formation of PHOSPHOCREATINE from ATP + CREATINE. The reaction stores ATP energy as phosphocreatine. Three cytoplasmic ISOENZYMES have been identified in human tissues: the MM type from SKELETAL MUSCLE, the MB type from myocardial tissue and the BB type from nervous tissue as well as a mitochondrial isoenzyme. Macro-creatine kinase refers to creatine kinase complexed with other serum proteins. Creatine Phosphokinase,ADP Phosphocreatine Phosphotransferase,ATP Creatine Phosphotransferase,Macro-Creatine Kinase,Creatine Phosphotransferase, ATP,Kinase, Creatine,Macro Creatine Kinase,Phosphocreatine Phosphotransferase, ADP,Phosphokinase, Creatine,Phosphotransferase, ADP Phosphocreatine,Phosphotransferase, ATP Creatine
D004078 Dihydralazine 1,4-Dihydrazinophthalazine. An antihypertensive agent with actions and uses similar to those of HYDRALAZINE. (From Martindale, The Extra Pharmacopoeia, 30th ed, p354) Depressan,Dihydralazine Sulfate,Dihydrallazine,Dihydrazinophthalazin,Sulfate, Dihydralazine
D005711 Gallopamil Coronary vasodilator that is an analog of iproveratril (VERAPAMIL) with one more methoxy group on the benzene ring. Methoxyverapamil,D-600,D600,Elgiprona,Gallobeta,Gallopamil Hydrochloride,Prebet,Procorum,gallopamil von ct,D 600,Hydrochloride, Gallopamil
D006439 Hemodynamics The movement and the forces involved in the movement of the blood through the CARDIOVASCULAR SYSTEM. Hemodynamic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

H U Lehmann, and H Hochrein, and E Witt, and H W Mies
Renal hemodynamic effects of calcium antagonists.
January 1988, Journal of cardiovascular pharmacology,
H U Lehmann, and H Hochrein, and E Witt, and H W Mies
Renal hemodynamic effects of calcium antagonists.
March 1987, The American journal of medicine,
H U Lehmann, and H Hochrein, and E Witt, and H W Mies
Renal hemodynamic effects of calcium antagonists.
September 1989, The American journal of cardiology,
H U Lehmann, and H Hochrein, and E Witt, and H W Mies
[Calcium antagonists: hemodynamic effects in hypertensive patients].
January 1979, Bollettino della Societa italiana di cardiologia,
H U Lehmann, and H Hochrein, and E Witt, and H W Mies
Hemodynamic effects of calcium antagonists in cardiac patients.
January 1982, Cardiology,
H U Lehmann, and H Hochrein, and E Witt, and H W Mies
[Regional hemodynamic and metabolic effects of calcium antagonists].
January 1979, Bollettino della Societa italiana di cardiologia,
H U Lehmann, and H Hochrein, and E Witt, and H W Mies
[Acute unusual hemodynamic effects of the calcium-antagonists].
September 1985, La Clinica terapeutica,
H U Lehmann, and H Hochrein, and E Witt, and H W Mies
Hemodynamic and counterregulatory effects of calcium antagonists in hypertension.
January 1988, Journal of cardiovascular pharmacology,
H U Lehmann, and H Hochrein, and E Witt, and H W Mies
Renal hemodynamic effects of calcium antagonists: implications for renal transplantation.
April 1991, Transplantation proceedings,
H U Lehmann, and H Hochrein, and E Witt, and H W Mies
Hemodynamic effects of calcium ion antagonists after acute myocardial infarction.
January 1980, Clinical and investigative medicine. Medecine clinique et experimentale,
Copied contents to your clipboard!